Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Chen, Yu-An, Lin, Ying-Ju, Lin, Cheng-Li, Lin, Hwai-Jeng, Wu, Hua-Shan, Hsu, Hui-Ying, Sun, Yu-Chen, Wu, Hui-Yu, Lai, Chih-Ho, Kao, Chia-Hung
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://ncbi.nlm.nih.gov/pubmed/29623039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00225
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars